0 Comentários
0 Compartilhamentos
156 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Alzheimer's Disease Diagnostic Market: How Is the Alzheimer's Diagnostic Market Being Transformed by New Treatments?FDA-approved amyloid-targeting therapies — lecanemab (Leqembi) and donanemab (Kisunla) receiving FDA approval for early AD treatment — have fundamentally transformed Alzheimer's diagnostics from a primarily academic exercise toward a clinically necessary component of treatment pathway qualification, with the Alzheimer's Disease Diagnostic Market reflecting the treatment-driven...0 Comentários 0 Compartilhamentos 26 Visualizações 0 Anterior
-
Alzheimer's Disease Therapeutics Market: Pipeline Drugs, Biomarker Innovation, and Market Size Forecast"Competitive Analysis of Executive Summary Alzheimer’s Disease Market Size and Share Data Bridge Market Research analyzes that the Alzheimer’s disease market which was USD 5.10 billion in 2022, is likely to reach USD 9.73 billion by 2030, and is expected to undergo a CAGR of 8.40% during the forecast period. To stand apart from the competition, a careful idea about the...0 Comentários 0 Compartilhamentos 748 Visualizações 0 Anterior
-
Alzheimer’s Disease Diagnostic Market Key Manufacturers: Leading Players and StrategiesThe Alzheimer’s Disease Diagnostic Market Key Manufacturers include Roche, GE Healthcare, Siemens Healthineers, Eli Lilly, and Biogen. These companies dominate due to strong R&D capabilities, broad distribution networks, and robust product portfolios. Imaging solutions, biomarker assays, and AI-assisted diagnostics remain core revenue drivers. Key manufacturers are focusing on...0 Comentários 0 Compartilhamentos 934 Visualizações 0 Anterior
-
Alzheimer’s Disease Market Size & Future Forecast"Executive Summary Alzheimer’s Disease Market Trends: Share, Size, and Future Forecast Data Bridge Market Research analyzes that the Alzheimer’s disease market which was USD 5.10 billion in 2022, is likely to reach USD 9.73 billion by 2030, and is expected to undergo a CAGR of 8.40% during the forecast period. The Alzheimer’s Disease Market report...0 Comentários 0 Compartilhamentos 765 Visualizações 0 Anterior
-
Alzheimer’s Disease Treatment Market Analysis and Growth Outlook"What’s Fueling Executive Summary Alzheimer’s Disease Treatment Market Market Size and Share Growth Data Bridge Market Research analyses that the Alzheimer’s disease treatment will exhibit a CAGR of around 8.79% for the forecast period of 2022-2029. To stand apart from the competition, a careful idea about the competitive landscape, their product range, their...0 Comentários 0 Compartilhamentos 865 Visualizações 0 Anterior
-
Rising Challenges and Opportunities in the Dementia–Alzheimer’s Disease Market and Forecast to 2030Data Bridge Market Research analyses that the market, which was USD 13,000.00 million in 2022, would rocket up to USD 25,000.00 million by 2030 and is expected to undergo a CAGR of 8.5% during the forecast period. Dementia, with Alzheimer’s disease as its most prevalent form, continues to emerge as one of the most pressing global health challenges. Characterized by progressive cognitive...0 Comentários 0 Compartilhamentos 886 Visualizações 0 Anterior
-
The "Neurological" Horizon: How 2026 is Using "Hot" Molecules to Treat Alzheimer's.In late 2026, the industry is pivoting toward "Neuro-Theranostics." While oncology remains the anchor, a radical new class of "Amyloid-Clearing Radiopharmaceuticals" has entered Phase 2 trials, aiming to use targeted radiation to break down the plaques associated with Alzheimer's disease. This innovation is a primary driver for the market, as it promises to treat the brain with...0 Comentários 0 Compartilhamentos 327 Visualizações 0 Anterior
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek